Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |